3/25
08:30 am
hscs
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category
Medium
Report
HeartSciences’ MyoVista Insights™ Receives Epic Toolbox Designation for ECG Management System Category
3/24
11:18 am
hscs
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
Low
Report
HeartSciences to Present at Investor Summit Group Virtual Conference and Host Virtual One on One Investor Meetings
3/24
08:03 am
hscs
HeartSciences (HSCS) had its price target lowered by Ascendiant Capital Markets from $9.00 to $8.00. They now have a "buy" rating on the stock.
Medium
Report
HeartSciences (HSCS) had its price target lowered by Ascendiant Capital Markets from $9.00 to $8.00. They now have a "buy" rating on the stock.
3/16
04:15 pm
hscs
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
Medium
Report
HeartSciences Reports Fiscal Third Quarter 2026 Financial Results and Provides Business Update
2/5
08:30 am
hscs
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
Medium
Report
University of West England Adopts HeartSciences’ MyoVista Insights™ Platform and MyoVista® wavECG™ Device to Establish ECG Education and Technology Reference Center
1/29
08:30 am
hscs
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals
Medium
Report
Cibolo Health Designates HeartSciences’ MyoVista Insights™ as Endorsed ECG Management Platform for Network of 123 Independent Hospitals